{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:12:08Z","timestamp":1782166328810,"version":"3.54.5"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome, a type of chronic inflammatory disease, is rare and difficult to treat. Osteoarthropathy with skin involvement is the primary clinical manifestation of SAPHO syndrome. The unknown pathogenesis of SAPHO syndrome is speculated to be related to individual genetic differences, immune levels, microorganisms, and environmental factors. Tofacitinib, a novel small-molecule Janus kinase (JAK) inhibitor, has been used to treat rheumatoid arthritis. However, it also has great potential for the treatment of other immune diseases, including SAPHO syndrome. A 36-year-old man with chest and back pain for more than two months was admitted to our hospital. After admission, the patient developed a pustular rash and enteritis. SAPHO syndrome was diagnosed based on the above clinical manifestations, computed tomography (CT), and bone scintigraphy findings. Notably, the patient also had ankylosing spondylitis. Tofacitinib significantly improved the patient\u2019s skin symptoms while preventing worsening of chest and back pain when adalimumab was discontinued. We report the first case of ankylosing spondylitis with SAPHO syndrome. In\u00a0addition, it is also the first successful treatment thereof with tofacitinib. We hope to provide valuable information regarding the pathogenesis and treatment of SAPHO syndrome in this case.<\/jats:p>","DOI":"10.3389\/fimmu.2022.911922","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T05:29:30Z","timestamp":1653456570000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["SAPHO Syndrome Complicated by Ankylosing Spondylitis Successfully Treated With Tofacitinib: A Case Report"],"prefix":"10.3389","volume":"13","author":[{"given":"Fangfang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"B1","article-title":"[Acne-Pustulosis-Hyperostosis-Osteitis Syndrome. Results of a National Survey. 85 Cases]","volume":"3","author":"Chamot","year":"1987","journal-title":"Rev du Rhumatisme Des Maladies Osteo Articulaires"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181393","article-title":"Copy Number Variation of Multiple Genes in SAPHO Syndrome","volume":"9","author":"Guo","year":"2020","journal-title":"J Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.874760","article-title":"Antibiotics may be Useful in the Treatment of SAPHO Syndrome","volume":"4","author":"Colina","year":"2014","journal-title":"Modern Rheumatol"},{"key":"B4","first-page":"35","article-title":"Serum IgG4 Elevation in SAPHO Syndrome: Does it Unmask a Disease Activity Marker","volume":"1","author":"Li","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew015","article-title":"Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis Syndrome: A Single Centre Study of a Cohort of 164 Patients","volume":"6","author":"Li","year":"2016","journal-title":"Rheumatol (Oxford England)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-016-0583-y","article-title":"SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment","volume":"6","author":"Firinu","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217854","article-title":"Off-Label Use of Tofacitinib: A Potential Treatment Option for SAPHO Syndrome, Annals of the Rheumatic Diseases","author":"Xie","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3579(94)80022-7","article-title":"The SAPHO Syndrome","volume":"2","author":"Kahn","year":"1994","journal-title":"Bailliere\u2019s Clin Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00124743-200202000-00005","article-title":"A Study of Musculoskeletal Manifestations in 12 Patients With SAPHO Syndrome","volume":"1","author":"Steinhoff","year":"2002","journal-title":"J Clin Rheumatol: Pract Rep Rheum Musculoskeletal Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.4261","article-title":"Clinical Symptoms, Imaging, and Treatment of SAPHO Syndrome: A Single\u2212Center Study of 52 Cases","volume":"6","author":"Przepiera-B\u0119dzak","year":"2018","journal-title":"Polish Arch Internal Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcz125","article-title":"The SAPHO Syndrome and the Bullhead Sign","volume":"2","author":"Liu","year":"2020","journal-title":"QJM: Monthly J Assoc Physicians"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2020.97394","article-title":"SAPHO Syndrome: Pathogenesis, Clinical Presentation, Imaging, Comorbidities and Treatment: A Review","volume":"6","author":"Przepiera-B\u0119dzak","year":"2021","journal-title":"Postepy Dermatologii i Alergologii"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005724","article-title":"The Coexistence of SAPHO Syndrome and Rheumatoid Arthritis: A Case Report","volume":"1","author":"Xu","year":"2017","journal-title":"Medicine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2016.0112","article-title":"Different Contributions of CDKAL1, KIF21B, and LRRK2\/MUC19 Polymorphisms to SAPHO Syndrome, Rheumatoid Arthritis, Ankylosing Spondylitis, and Seronegative Spondyloarthropathy","volume":"33","author":"Li","year":"2017","journal-title":"Genet Testing Mol Biomarkers"},{"key":"B15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","article-title":"HLA-B27","author":"Bowness","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B16","article-title":"SAPHO Syndrome: A Followup Study of 19 Cases With Special Emphasis on Enthesis Involvement","volume":"11","author":"Maugars","year":"1995","journal-title":"J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.56","article-title":"Pathogenesis of Ankylosing Spondylitis - Recent Advances and Future Directions, Nature Reviews","volume":"6","author":"Ranganathan","year":"2017","journal-title":"Rheumatology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00001","article-title":"Anti-IL17A in Axial Spondyloarthritis-Where Are We at","volume":"1","author":"Cheung","year":"2017","journal-title":"Front Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2014.906582","article-title":"TH17 Cells are Increased in the Peripheral Blood of Patients With SAPHO Syndrome","volume":"6","author":"Firinu","year":"2014","journal-title":"Autoimmunity"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2020.103673","article-title":"Exosomal Proteome From the Serum, Bone Marrow, and Palm and Toe Pustular Skin Tissues of a Single Patient With SAPHO Syndrome","volume":"216","author":"Liu","year":"2020","journal-title":"J Proteomics"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2017.05.016","article-title":"IL-23\/Th17 Targeted Therapies in SAPHO Syndrome. A Case Series","volume":"6","author":"Wendling","year":"2017","journal-title":"Joint Bone Spine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219601","article-title":"Tofacitinib for the Treatment of Ankylosing Spondylitis: A Phase III, Randomised, Double-Blind, Placebo-Controlled Study","volume":"8","author":"Deodhar","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-207201","article-title":"Tofacitinib Regulates Synovial Inflammation in Psoriatic Arthritis, Inhibiting STAT Activation and Induction of Negative Feedback Inhibitors","volume":"1","author":"Gao","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.03.021","article-title":"Stattic Inhibits RANKL-Mediated Osteoclastogenesis by Suppressing Activation of STAT3 and NF-\u03bab Pathways","volume":"58","author":"Li","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.3095","article-title":"Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome","volume":"1","author":"Li","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i19.4527","article-title":"Rapid Remission of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome in Response to the Janus Kinase Inhibitor Tofacitinib: A Case Report","volume":"19","author":"Li","year":"2020","journal-title":"World J Clin cases"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000441","article-title":"Improvement of Lymphangioleiomyomatosis Following Successful Tofacitinib Treatment for Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome","volume":"19","author":"Liu","year":"2019","journal-title":"Chin Med J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011149","article-title":"Case Report: Successful Treatment of Refractory SAPHO Syndrome With the JAK Inhibitor Tofacitinib","volume":"25","author":"Yang","year":"2018","journal-title":"Medicine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217250","article-title":"Efficacy of Tofacitinib in Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis Syndrome: A Pilot Study With Clinical and MRI Evaluation","volume":"9","author":"Li","year":"2020","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.911922\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T05:29:35Z","timestamp":1653456575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.911922\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2022.911922"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.911922","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"article-number":"911922"}}